Integra LifeSciences Holdings Corporation (IART) free cash flow

Free cash flow · fiscal 2025
-$45.25M

Integra LifeSciences Holdings Corporation (IART) generated free cash flow of -$45.25M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was $15.01M. Figures as of 18 Nov 2026, 12:28 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
-$45.25M
Highest on record
$264.41Mfiscal 2021
Lowest on record
-$45.25Mfiscal 2025
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Integra LifeSciences Holdings Corporation free cash flow, in more detail

Across the 18 fiscal years on record (2008–2025), the highest was $264.41M in fiscal 2021 and the lowest -$45.25M in fiscal 2025.

History · 18 fiscal years

Free cash flow by fiscal year

Integra LifeSciences Holdings Corporation free cash flow, year by year

Integra LifeSciences Holdings Corporation (IART) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025-$45.25M 401.5% down
2024$15.01M 79.5% down
2023$73.09M 66.4% down
2022$217.38M 17.8% down
2021$264.41M 60.3% up
2020$164.94M 1.9% up
2019$161.90M 32.8% up
2018$121.94M 71.7% up
2017$71.04M 2.8% up
2016$69.08M 3.3% down
2015$71.44M 58.0% up
2014$45.23M 312.4% up
2013$10.97M—
2012-$9.93M 115.1% down
2011$65.90M 3.7% down
2010$68.43M 42.0% down
2009$118.00M 99.4% up
2008$59.19M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

More on IART

Integra LifeSciences Holdings Corporation, figure by figure

Integra LifeSciences Holdings Corporation (IART) overview: price, valuation and scorecard

Integra LifeSciences Holdings Corporation free cash flow: questions and answers

What is Integra LifeSciences Holdings Corporation's free cash flow?

Integra LifeSciences Holdings Corporation (IART) generated free cash flow of -$45.25M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was $15.01M.

What are the highest and lowest free cash flow figures on record for Integra LifeSciences Holdings Corporation?

Across the 18 fiscal years on record (2008–2025), the highest was $264.41M in fiscal 2021 and the lowest -$45.25M in fiscal 2025.

How is Integra LifeSciences Holdings Corporation's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Integra LifeSciences Holdings Corporation it is on record here for 18 fiscal years, 2008 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Integra LifeSciences Holdings Corporation (IART) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/IART/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.